Influence of various risk factors that affect survival outcome after HCT (univariate analysis)
Features . | Percentage . | n/N . | OS, % . | HR . | 95% CI . | P . |
---|---|---|---|---|---|---|
Donor source | ||||||
MSD | 41 | 42/106 | 86 | |||
MFD | 13 | 12/106 | 83 | 0.73 | 0.1287-4.158 | .72 |
MUD | 14 | 15/106 | 67 | 0.263 | 0.063 65-1.92 | .05 |
MMUD | 7 | 7/106 | 29 | 0.01459 | 0.001924-0.1107 | < .001 |
HAPLO | 28 | 30/106 | 43 | 0.1629 | 0.068 24-0.3887 | < .001 |
Conditioning | ||||||
None | 46 | 49/106 | 78 | |||
RIC | 11 | 12/106 | 67 | 0.51 | 0.1336-1.967 | .29 |
MAC | 42 | 45/106 | 56 | 0.407 | 0.1996-0.8333 | .009 |
PEG-ADA | ||||||
No | 88 | 93/106 | 67 | |||
Yes > 3 mo | 12 | 13/106 | 69 | 1.034 | 0.3690-2.898 | .97 |
Age at transplantation | ||||||
Birth to 6 mo | 63 | 67/106 | 72 | |||
6-12 mo | 25 | 26/106 | 58 | 0.556 | 0.2443-1.266 | .20 |
1-5 y | 11 | 12/106 | 58 | 0.6253 | 0.2026-1.930 | .59 |
> 5 y | 1 | 1/106 | ||||
dATP levels | ||||||
0-1000μM | 43 | 20/46 | 55 | |||
> 1000μM | 56 | 26/46 | 73 | 1.829 | 0.6734-4.968 | .28 |
Stem cell source | ||||||
BM | 83 | 88/106 | 68 | |||
PBSC | 8 | 9/106 | 67 | 0.8107 | 0.2228-2.950 | .58 |
UCB | 8 | 9/106 | 56 | 0.4496 | 0.1171-1.726 | .16 |
Features . | Percentage . | n/N . | OS, % . | HR . | 95% CI . | P . |
---|---|---|---|---|---|---|
Donor source | ||||||
MSD | 41 | 42/106 | 86 | |||
MFD | 13 | 12/106 | 83 | 0.73 | 0.1287-4.158 | .72 |
MUD | 14 | 15/106 | 67 | 0.263 | 0.063 65-1.92 | .05 |
MMUD | 7 | 7/106 | 29 | 0.01459 | 0.001924-0.1107 | < .001 |
HAPLO | 28 | 30/106 | 43 | 0.1629 | 0.068 24-0.3887 | < .001 |
Conditioning | ||||||
None | 46 | 49/106 | 78 | |||
RIC | 11 | 12/106 | 67 | 0.51 | 0.1336-1.967 | .29 |
MAC | 42 | 45/106 | 56 | 0.407 | 0.1996-0.8333 | .009 |
PEG-ADA | ||||||
No | 88 | 93/106 | 67 | |||
Yes > 3 mo | 12 | 13/106 | 69 | 1.034 | 0.3690-2.898 | .97 |
Age at transplantation | ||||||
Birth to 6 mo | 63 | 67/106 | 72 | |||
6-12 mo | 25 | 26/106 | 58 | 0.556 | 0.2443-1.266 | .20 |
1-5 y | 11 | 12/106 | 58 | 0.6253 | 0.2026-1.930 | .59 |
> 5 y | 1 | 1/106 | ||||
dATP levels | ||||||
0-1000μM | 43 | 20/46 | 55 | |||
> 1000μM | 56 | 26/46 | 73 | 1.829 | 0.6734-4.968 | .28 |
Stem cell source | ||||||
BM | 83 | 88/106 | 68 | |||
PBSC | 8 | 9/106 | 67 | 0.8107 | 0.2228-2.950 | .58 |
UCB | 8 | 9/106 | 56 | 0.4496 | 0.1171-1.726 | .16 |
OS indicates overall survival; HR, hazard ratio; and CI, confidence interval. For additional abbreviation expansions please see Table 1.